Twitter LinkedIn
    Monday, May 23
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Deals & Transactions»Oxford scientists raise VC investment to create variant-proof vaccines
    Deals & Transactions

    Oxford scientists raise VC investment to create variant-proof vaccines

    April 3, 20211 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Baseimmune, an early-stage UK biotech startup, is combining big data and biological expertise to predict how viruses will change and identify ‘future-proof’ antigens that will form the crucial elements of the next generation of vaccines. 

    In order to further the development of its platform and start pre-clinical development in the lab, Baseimmune has secured a GBP685,000 investment, led by European university VC fund, Creator Fund, and includes Mike Watson, ex-president of Moderna’s infectious disease spin-out with the support of Vaccitech and Oxford University. Maki VC and Rockmount Seed Investments also joined the round.

    The team has also initiated the preclinical development of a number of its own vaccine candidates including a universal Covid vaccine and a veterinary vaccine against African Swine Fever Virus (ASFV).

    Baseimmune’s software generates vaccine antigens associated with agricultural and human diseases, such as Malaria and Covid.

    Read more at Private Equity Wire

    Image Source

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    COVID-19 Investments
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Vista Equity Partners Among the First Major U.S. Private Equity Firms to Advance Global ESG Strategy with Portfolio-Wide Participation in Climate Program

    May 23, 2022

    General Atlantic eyeing $2 bn investment in India, SE Asia

    May 23, 2022

    Buyout Firm Bridgepoint Weighs $2 Billion Sale of Software Provider Kyriba

    May 23, 2022

    Air France-KLM Talking With Apollo on $528 Million Injection

    May 23, 2022

    Comments are closed.

    Other Articles

    PGIM acquires €2.7bn private equities secondaries manager Montana Capital Partners

    July 13, 2021

    IBM to acquire software provider Turbonomic for over $1.5 bln Krystal Hu

    May 2, 2021

    MTG sells ESL Gaming to PIF-backed Savvy Gaming Group for $1.05bn

    January 25, 2022

    Abu Dhabi fund, CVC, among suitors for $1 billion NMC hospital business

    March 5, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2022 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?